APLAZYL<sup>®</sup>

APLAZYL®

  • Feed additive
  • Divisible tablets of 1.250 mg
  • Boxes of 60, 120, 300 or 600 divisible tablets
Cats
Dogs

Guaranteed contents: Raw protein: 37,8 % – Raw ashes: 14,0 % – Raw fat: 10,0 % – Raw fibre: 0,5 %.
Additive: trace elements: Manganese chelate of amino acids, hydrated, manganese: 2.400 mg/kg. Flavouring, plant extracts: Extracts from devilsclaw (Harpagophytum procumbens) 1.600 mg/kg – Extracts from incense (Boswellia serrata) 6.000 mg/kg.
Composition: Powder of green-lipped mussel (Perna canaliculus) – Glucosamine sulfate – Chondroïtine sulfate – Powder of green alga (Chlorella pyrenoïdosa) – Fish oil – Powder of stinging nettle (Urtica urens).

Characteristics

APLAZYL® is a feed complement which supports the locomotor functions and maintains the articulations healthy. APLAZYL® lubricates the articulations, supports and preserves the cartilage, meets the increased nutritional needs of the locomotor apparatus during the growth and the periods of intense efforts and maintains the flexibility of the articulations.

Target species

Dogs and cats

Use

APLAZYL® is used in aged animals, also advised during the growth, in period of convalescence or revalidation, in the sporting animal in period of preparation and recovery, in the nursing or carrying female.

Directions for use

Oral administration, in the feed or directly in the mouth.

Puppies in growth period

½ tablet per day, from the 6th week to the 6th month.

Convalescing dogs, sportive dogs or dogs presenting with stiffness

1 tablet/day/10 kg body weight, during 1 to 2 months.

Aged dogs, gestating or suckling bitches

< 20 kg: 1 tablet/day
> 20 kg: 2 tablets/day.

Aged, stiff, convalescing cats

½ tablet/day/5 kg body weight.
A cure of 6 to 12 weeks is recommended, 2 times per year for the maintaining of aged animals, 30 days before the birth till 60 days after the birth for gestating animals.

Storage

At ambient temperature in the original packing and out of reach of children.

Packaging

Box containing 60, 120, 300 or 600 divisible tablets under blister.

Extra information

Prodivet pharmaceuticals sa/nv
Hagbenden 39c
B-4731 EYNATTEN
Tel. +32(0)87 85 20 25
info@prodivet.com
www.prodivet.com
BE 0423.519.816

Authorization number: AFSCA HN1775

2010V5B